An asymptomatic 64-year-old patient came for a routine check-up following inferior wall myocardial infarction (MI) and stent insertion in France 6 months previously. He had no cardiovascular risk factors or significant past medical history. Systemic examination was normal as were his haematological and biochemical parameters. A routine echocardiogram (TTE) revealed a mass on the non-coronary leaflet of the aortic valve (AV) with normal left ventricular function and no other valvular abnormalities. Subsequent transoesophageal echocardiography confirmed a pedunculated echogenic mobile mass 0.5–1 cm in diameter attached to the aortic side of AV (Fig. 1a and online video files). Further imaging with cardiac MR described the hypointense mobile mass as possible fibroelastoma. The patient underwent excision of the tumour (Fig. 1b) and AV replacement. Histopathology revealed a central fibrous core surrounded by a layer of loose connective tissue with variable elastic tissue with the surface covered by endothelial cells, consistent with papillary fibroelastoma (Fig. 2). His post-operative recovery was uneventful and was later discharged. Papillary fibroelastoma is a rare, benign cardiac tumour accounting for 10 % of all cardiac tumours [1]. They are generally found on aortic and mitral valves. Patients may present with neurological events, stroke, angina, myocardial infarction, sudden death or as incidental findings on autopsy or at surgery. TTE is useful in making the diagnosis. Treatment in asymptomatic patients is controversial. However, left-sided tumours may be considered for surgery as they can embolise causing strokes, MI, peripheral ischaemia and even vascular obstruction. Though rightsided tumours follow a more benign course, they can interfere with cardiac output if bulky enough.